Skip to main content
Han Tun, MD, Oncology, Jacksonville, FL, Mayo Clinic Hospital in Florida

HanWinTunMD

Oncology Jacksonville, FL

Professor of Medicine at Mayo Clinic in Florida

Dr. Tun is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Tun's full profile

Already have an account?

Education & Training

  • Mayo Clinic College of Medicine and Science (Rochester)
    Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Hematology and Medical Oncology, 1998 - 2001
  • MedStar Health/Harbor Hospital
    MedStar Health/Harbor HospitalResidency, Internal Medicine, 1995 - 1998
  • University Institute of Medicine 1
    University Institute of Medicine 1Class of 1990

Certifications & Licensure

  • FL State Medical License
    FL State Medical License 1998 - 2026
  • MD State Medical License
    MD State Medical License 1997 - 1999
  • American Board of Internal Medicine Hematology

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Phase I Study of Pomalidomide and Dexamethasone for relapsed/refractory Primary CNS or Vitreo-Retinal Lymphoma  
    Lisa M DeAngelis, Han W Tun, David Schiff, Kurt A Jaeckle, Christian Grommes, Patrick B Johnston, Craig B Reeder, Thomas E Witzig, Blood

Abstracts/Posters

  • A Phase Ia/Ib Study Exploring the Synthetic Lethality of the Orally Administered Novel BTK Inhibitor, Dtrmwxhs-12 (DTRM-12), in Combination with Everolimus and Pomalid...
    Han W. Tun, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • The DIAL Study (Dual Immunomodulation in Aggressive Lymphoma): A Randomized Phase 2 Study of CDX-1127 (Varlilumab) in Combination with Nivolumab in Patients with Relap...
    Han W. Tun, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
  • Long-Term Outcome of Patients with Marginal Zone Non-Hodgkin Lymphoma (MZL) Treated with Yttrium-90 Ibritumomab Tiuxetan: The Mayo Clinic Experience
    Han W. Tun, 61st Annual American Society of Hematology Meeting, 61st Annual American Society of Hematology Meeting - Orlando, FL, 12/8/2019
  • Join now to see all

Press Mentions

  • Treasure Trove of Genes Key to Kidney Cancer Revealed by Research
    Treasure Trove of Genes Key to Kidney Cancer Revealed by ResearchJuly 1st, 2014

Professional Memberships

Hospital Affiliations